Professor Malcolm Grant (pictured), an authority on genetic technology, has been named by Health Secretary Andrew Lansley as his choice of Chair for the new NHS Commissioning Board.
The national board, which has been called the biggest quango in British history, will commission primary medical care and specialist health areas, as well as controlling the allocation of NHS resources.
Professor Grant, currently Provost of University College London, will be interviewed by the Health Select Committee before his appointment but is expected to take up the post at the end of October.
A qualified barrister and lawyer, Professor Grant has worked in the Local Government Commission and been a UK Business Ambassador. He is a recognised authority on the regulation of biotechnology.
Malcolm Grant commented: “We need to build on the very best NHS qualities of dedicated public service, professionalism and pride, and seize the opportunity to create long-term stability and focus on getting constant improvement in quality and openness to innovation.”
Grant’s commitment to new healthcare technology is reflected in his recent statement: “We know that there will be a revolution in the next few years as we try to ensure that improvements in diagnostics and pharmacogenetics and self-care and self-treatment are brought home to patients, giving them the capacity to control their own medication and their own choices.”
The NHS Commissioning Board will provide strategic leadership for NHS commissioning. It will directly commission primary medical care and some specialised healthcare; support and regulate the Clinical Commissioning Groups; allocate NHS resources; and promote patient choice and information.
Andrew Lansley said: “Professor Grant has distinction and authority, is outstandingly capable and has excellent leadership skills, demonstrated by his success at UCL. He has a strong track record of delivery in complex public sector organisations, and shares the public sector ethos and values of the NHS.”